Frank Luppino

Frank Luppino is the President and CEO of Remedium Bio, also serving as the Chairman of the Board of Directors. Prior to joining Remedium Frank’s successful track record includes the development, industrialization, and commercial launch of a broad array of products including Cell Therapies for wound and cartilage repair, anti-inflammatory and analgesic Drug-Device combination products in orthopedics and aesthetic medical markets, as well as biologic macromolecules for the prevention of surgical adhesions.

Prior to joining Remedium, Frank served in a series of executive roles including as the CEO of Biosource CXO, Chief Operating Officer of Anika Therapeutics, Vice President of Operations at Bionostics, and various roles of increasing responsibility at Raytheon and Black & Veatch. Frank holds a Bachelor of Science from Lehigh University.